X-linked Alport Syndrome with Type IV Collagen α5 Chain Staining Revealing Normal Expression in the Glomerular Basement Membrane and Negative on Bowman's Capsule and Distal Tubular Basement Membrane: A Case Report

Tohoku J Exp Med. 2023 Sep 20;261(1):69-73. doi: 10.1620/tjem.2023.J060. Epub 2023 Jul 27.

Abstract

X-linked Alport syndrome is a hereditary progressive renal disease resulting from the disruption of collagen α3α4α5 (IV) heterotrimerization caused by pathogenic variants in the COL4A5 gene. This study aimed to report a male case of X-linked Alport syndrome with a mild phenotype accompanied by an atypical expression pattern of type IV collagen α5 [α5 (IV)] chain in glomerulus. A 38-year-old male presented with proteinuria (2.3 g/day) and hematuria. He has been detected urinary protein and occult blood since childhood. A renal biopsy was performed at the age of 29 years; however, a diagnosis of Alport syndrome was not considered. A renal biopsy 9 years later revealed diffuse thinning and lamellation of the glomerular basement membrane. Α staining for α5 (IV) revealed a normal expression pattern in the glomerular basement membrane and a complete negative expression in Bowman's capsule and distal tubular basement membrane. Using next-generation sequencing, we detected a COL4A5 missense variant within exon 35 (NM_000495.5: c.3088G>A, p. G1030S). The possibility of X-linked Alport syndrome should be considered when negative expression of α5 (IV) staining on Bowman's capsule was observed.

Keywords: Bowmans’s capsules; X-linked Alport syndrome; distal tubular basement membrane; glomerular basement membrane; type IV collagen α5.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Bowman Capsule / metabolism
  • Bowman Capsule / pathology
  • Child
  • Collagen Type IV / genetics
  • Exons
  • Glomerular Basement Membrane / pathology
  • Humans
  • Male
  • Nephritis, Hereditary* / genetics
  • Nephritis, Hereditary* / metabolism
  • Nephritis, Hereditary* / pathology

Substances

  • Collagen Type IV